BIOLASE Inc
NASDAQ:BIOL
BIOLASE Inc
NASDAQ:BIOL
Price:
0.1768 USD
21.85%
Market Closed
Updated:
May 7, 2024
Section:
Relative Value
The Relative Value of one
BIOL
stock under the Base Case scenario is
5.1523
USD.
Compared to the current market price of 0.1768 USD,
BIOLASE Inc
is
Undervalued by 97%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BIOL
Relative Value
Base Case
5.1523
USD
Undervaluation 97%
Valuation Multiples
Multiples Across Competitors
BIOL Competitors Multiples
BIOLASE Inc Competitors
BIOLASE Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
BIOLASE Inc
NASDAQ:BIOL
|
5.9m USD | 0.1 | -0.2 | -0.7 | -0.6 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.8B USD | 4.6 | 32.6 | 19.3 | 28.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.9B USD | 18.6 | 68.4 | 56.1 | 70.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
124B USD | 5.9 | 36.9 | 24 | 29.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.7B USD | 3.4 | 25.9 | 13.8 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.6B USD | 7.3 | 60.4 | 30.4 | 45 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.3B USD | 3.5 | 56.1 | 18.8 | 39.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
58.5B EUR | 2.7 | 38.6 | 18.5 | 31.2 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
378.6B CNY | 11 | 33.3 | 29.1 | 29.1 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
51.4B USD | 13.5 | 80.3 | 60 | 78.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.2B USD | 8.3 | 36.2 | 26.3 | 28.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
